 Connection
Matthew Zipse to Cardiomyopathies
This is a "connection" page, showing publications Matthew Zipse has written about Cardiomyopathies.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
3.669 |
|
|
|
-
Zipse MM. Editorial commentary: Cardiac sarcoidosis in contemporary practice: Forward progress, but clinical quandaries persist. Trends Cardiovasc Med. 2023 10; 33(7):456-457.
Score: 0.594
-
Zipse MM, Tzou WS, Schuller JL, Aleong RG, Varosy PD, Tompkins C, Borne RT, Tumolo AZ, Sandhu A, Kim D, Freeman AM, Weinberger HD, Maier LA, Sung RK, Nguyen DT, Sauer WH. Electrophysiologic testing for diagnostic evaluation and risk stratification in patients with suspected cardiac sarcoidosis with preserved left and right ventricular systolic function. J Cardiovasc Electrophysiol. 2019 10; 30(10):1939-1948.
Score: 0.485
-
Zipse MM, Tzou WS. Sudden cardiac death in nonischemic cardiomyopathy: Refining risk assessment. J Cardiovasc Electrophysiol. 2017 Nov; 28(11):1361-1366.
Score: 0.422
-
Zipse MM, Sauer WH. Cardiac sarcoidosis and consequent arrhythmias. Card Electrophysiol Clin. 2015 Jun; 7(2):235-49.
Score: 0.360
-
Zipse MM, Sauer WH. Cardiac sarcoidosis. Curr Cardiol Rep. 2014 Aug; 16(8):514.
Score: 0.343
-
Zipse MM, Sauer WH. Electrophysiologic manifestations of cardiac sarcoidosis. Curr Opin Pulm Med. 2013 Sep; 19(5):485-92.
Score: 0.322
-
Slaven S, Garg L, Sabzwari R, Barrett C, Tumolo A, Cerbin L, Sandhu A, Zipse M, Tzou W, Rosenberg M. Burden of Premature Ventricular Complexes and Risk of Cardiomyopathy: A Cross-Sectional Study. JACC Clin Electrophysiol. 2025 May; 11(5):894-903.
Score: 0.178
-
Myadam R, Crawford TC, Bogun FM, Gu X, Ellenbogen KA, Jasti S, Chicos AB, Roukoz H, Zimetbaum PJ, Kalbfleisch SJ, Murgatroyd FD, Steckman DA, Rosenfeld LE, Garlitski AC, Soejima K, Bhan AK, Vedantham V, Dickfeld TL, De Lurgio DB, Platonov PG, Zipse MM, Nishiuchi S, Ortman ML, Narasimhan C, Patton KK, Rosenthal DG, Mukerji SS, Hoogendoorn JC, Zeppenfeld K, Sauer WH, Kron J. Reply: Association of Adverse Events With the Different Diagnostic Schemes of Cardiac Sarcoidosis. JACC Clin Electrophysiol. 2023 12; 9(12):2662-2663.
Score: 0.164
-
Myadam R, Crawford TC, Bogun FM, Gu X, Ellenbogen KA, Jasti S, Chicos AB, Roukoz H, Zimetbaum PJ, Kalbfleisch SJ, Murgatroyd FD, Steckman DA, Rosenfeld LE, Garlitski AC, Soejima K, Bhan AK, Vedantham V, Dickfeld TL, De Lurgio DB, Platonov PG, Zipse MM, Nishiuchi S, Ortman ML, Narasimhan C, Patton KK, Rosenthal DG, Mukerji SS, Hoogendoorn JC, Zeppenfeld K, Sauer WH, Kron J. Risk of Adverse Outcomes Associated?With Cardiac Sarcoidosis Diagnostic Schemes. JACC Clin Electrophysiol. 2023 08; 9(8 Pt 3):1719-1729.
Score: 0.158
-
Bressi E, Crawford TC, Bogun FM, Gu X, Ellenbogen KA, Chicos AB, Roukoz H, Zimetbaum PJ, Kalbfleisch SJ, Murgatroyd FD, Steckman DA, Rosenfeld LE, Garlitski AC, Soejima K, Bhan AK, Vedantham V, Dickfeld TM, De Lurgio DB, Platonov PG, Zipse MM, Nishiuchi S, Ortman ML, Narasimhan C, Patton KK, Rosenthal DG, Mukerji SS, Hoogendoorn JC, Zeppenfeld K, Sauer WH, Kron J. Arrhythmia Monitoring and Outcomes in Patients With Cardiac Sarcoidosis: Insights From the Cardiac Sarcoidosis Consortium. J Am Heart Assoc. 2022 07 05; 11(13):e024924.
Score: 0.148
-
Siontis KC, Santangeli P, Muser D, Marchlinski FE, Zeppenfeld K, Hoogendoorn JC, Narasimhan C, Sauer WH, Zipse MM, Kapa S, Vedantham V, Rosenthal DG, Robinson MR, Patton KK, Murgatroyd F, Chicos AB, Soejima K, Roukoz H, Sacher F, Bhan A, Appelbaum J, Dickfeld T, Mankad P, Ellenbogen KA, Kron J, Kim HM, Froehlich J, Eagle KA, Bogun FM, Crawford TC. Outcomes Associated With Catheter Ablation of Ventricular Tachycardia in Patients With Cardiac Sarcoidosis. JAMA Cardiol. 2022 02 01; 7(2):175-183.
Score: 0.144
-
Tzou WS, Rothstein PA, Cowherd M, Zipse MM, Tompkins C, Marzec L, Aleong RG, Schuller JL, Varosy PD, Borne RT, Mathew J, Tumolo A, Sandhu A, Nguyen DT, Sauer WH. Repeat ablation of refractory ventricular arrhythmias in patients with nonischemic cardiomyopathy: Impact of midmyocardial substrate and role of adjunctive ablation techniques. J Cardiovasc Electrophysiol. 2018 10; 29(10):1403-1412.
Score: 0.113
-
Zipse MM, Tzou WS. Resynchronization Therapy in Cardiac Sarcoidosis and Severe Heart Failure: When Good May Not Be Good Enough. J Cardiovasc Electrophysiol. 2017 02; 28(2):182-184.
Score: 0.102
-
Schuller JL, Olson MD, Zipse MM, Schneider PM, Aleong RG, Wienberger HD, Varosy PD, Sauer WH. Electrocardiographic characteristics in patients with pulmonary sarcoidosis indicating cardiac involvement. J Cardiovasc Electrophysiol. 2011 Nov; 22(11):1243-8.
Score: 0.069
-
Schuller JL, Lowery CM, Zipse M, Aleong RG, Varosy PD, Weinberger HD, Sauer WH. Diagnostic utility of signal-averaged electrocardiography for detection of cardiac sarcoidosis. Ann Noninvasive Electrocardiol. 2011 Jan; 16(1):70-6.
Score: 0.067
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|